SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
14640384
Source:
http://linkedlifedata.com/resource/pubmed/id/14640384
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0013893
,
umls-concept:C0200635
,
umls-concept:C0237401
,
umls-concept:C0243009
,
umls-concept:C0542559
,
umls-concept:C1963724
pubmed:issue
5
pubmed:dateCreated
2003-11-26
pubmed:abstractText
To characterize the value of total lymphocyte counts in predicting risk of death among patients initiating triple combination antiretroviral therapy.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9815705
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Protease Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1359-6535
pubmed:author
pubmed-author:BedellRichardR
,
pubmed-author:HeathKatherine VKV
,
pubmed-author:HoggRobert SRS
,
pubmed-author:MontanerJulio S GJS
,
pubmed-author:O'ShaughnessyMichael VMV
,
pubmed-author:PressNatashaN
,
pubmed-author:WoodEvanE
,
pubmed-author:YipBenitaB
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
379-84
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:14640384-Adolescent
,
pubmed-meshheading:14640384-Adult
,
pubmed-meshheading:14640384-Anti-HIV Agents
,
pubmed-meshheading:14640384-Antiretroviral Therapy, Highly Active
,
pubmed-meshheading:14640384-CD4 Lymphocyte Count
,
pubmed-meshheading:14640384-Cohort Studies
,
pubmed-meshheading:14640384-Disease Progression
,
pubmed-meshheading:14640384-Drug Therapy, Combination
,
pubmed-meshheading:14640384-Female
,
pubmed-meshheading:14640384-HIV Infections
,
pubmed-meshheading:14640384-HIV Protease Inhibitors
,
pubmed-meshheading:14640384-HIV-1
,
pubmed-meshheading:14640384-Humans
,
pubmed-meshheading:14640384-Lymphocyte Count
,
pubmed-meshheading:14640384-Male
,
pubmed-meshheading:14640384-Middle Aged
,
pubmed-meshheading:14640384-Poverty
,
pubmed-meshheading:14640384-Predictive Value of Tests
,
pubmed-meshheading:14640384-Proportional Hazards Models
,
pubmed-meshheading:14640384-Reverse Transcriptase Inhibitors
,
pubmed-meshheading:14640384-Survival Analysis
,
pubmed-meshheading:14640384-Viral Load
pubmed:year
2003
pubmed:articleTitle
Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
pubmed:affiliation
Centre for Excellence in HIV/AIDS, University of British Columbia, Vancouver, British Columbia, Canada.
pubmed:publicationType
Journal Article